Avoiding unplanned readmission into hospital is important. A significant proportion of hospital readmissions are avoidable and vulnerable groups, such as older people, are disproportionally affected by unplanned readmissions. Unplanned readmissions are associated with poorer health outcomes, lower satisfaction with healthcare, and increased health system costs.
The transition process between hospital and home is risky for the patient, however it is also a phase where patients may not necessarily need the intensity of a hospital bed, nor might patients actually want to remain in hospital especially if the same level of patient safety could be assured in the patient’s own home.
Tracey Johnson is the CEO of Inala Primary Care, a not-for-profit general practice located in Inala serving approximately 7000 patients; 4400 of whom attend clinic regularly. Inala is a suburb of Brisbane, Queensland and has a population of great cultural and linguistic diversity, with just under 40% of residents speaking English at home. It is also one of Queensland’s most socioeconomically marginalised urban areas.
Australian Health Journal spoke with Tracey on the role of Inala Primary care in reducing hospital admissions.
The delivery of care in a culturally and linguistically sensitive manner across all levels of the healthcare system is seen as deficient. In an effort to improve healthcare access and equity, Inala Primary Care and the Mater Integrated Refugee Health Service (MIRHS) co-developed the Mater Culturally & Linguistically Diverse Healthcare Coordinator Service (MCHooSe).
Commonly delivered services included following up with external health services, chart reviews and helping patients coordinate external health care appointments. Surveys of primary care clinicians (GPs and practice nurses) revealed that MCHooSe improved patient access to external health services and improved patient understanding of their treatments.
The data also revealed that the primary care clinicians felt the patients’ wellbeing improved after their patients had access to the service and that patients were more likely to be compliant with attendance and treatments. Most importantly, primary care clinicians said they received communications from the hospital quicker if MCHooSe was involved.
In combination, these factors are known to reduce the risk of hospital readmissions. MCHooSe highlights the potential to improve hospital outcomes through better healthcare coordination and improved healthcare equity for multicultural patients.
Tracey also talks about the outcomes of non-dispensing pharmacists in general practice in a pilot running at Inala Primary Care. Prior health research has shown the integration of non-dispensing pharmacists in the general practice clinic has significantly reduced emergency department presentations and hospital readmissions in certain patient groups (long-term polypharmacy suffering from congestive heart failure or chronic obstructive pulmonary disease).
As part of the pilot, pharmacists are working towards averting hospital readmissions, new hospital presentations and adverse health outcomes. Formal evaluation of the pilot is currently being completed by Brisbane South PHN and Griffith University.
You Might also like
-
Psychiatrists to discuss connectedness at RANZCP 2023 Congress
Next week, at the Perth Convention and Exhibition Centre, The Royal Australian and New Zealand College of Psychiatrists (RANZCP) meet for the RANZCP 2023 Congress on the theme of “New Horizons: Connected Futures”
Australian Health Journal spoke to current President-Elect Dr Elizabeth Moore and soon to be President, RANZCP about the Congress, as well as the recent Federal Budget announcements around mental health funding.
-
ACN National Nursing Forum 2019
The Australian College of Nursing National Nursing Forum was held in Hobart Tasmania in August 2019.
-
Using human skin hair follicles to treat Alzheimer’s disease
Professor Michael Valenzuela is a science opinion leader, innovator and creative thinker with a career-long commitment to the prevention and treatment of dementia.
Following that he completed graduate medicine and medical training at the Prince of Wales Hospital. In 2012, he established the Regenerative Neuroscience Group at the University of Sydney, and in 2017 became the university’s first Professor of Regenerative Medicine.
Professor Valenzuela’s group discovered a new cell type with potential for regenerative medicine, a rare neural precursor cell found deep within the human hair follicle. He is the main inventor on several related patents and is the Founder and Chief Scientific Officer of Skin2Neuron – a biotech company developing the first neurorestorative cell therapy for Alzheimer’s disease based on this work.